Review
Leukemia (2005) 19, 1128–1134. doi:10.1038/sj.leu.2403797 Published online 19 May 2005
What have we learnt from mouse models of NPM-ALK-induced lymphomagenesis?
S D Turner1 and D R Alexander1
1Laboratory of Lymphocyte Signalling and Development, The Babraham Institute, Babraham Research Campus, Cambridge CB2 4AT, UK
Correspondence: Dr SD Turner, LLSD, The Babraham Institute, Babraham Hall, Babraham Research Campus, Cambridge CB2 4AT, UK. Fax: +44 (0)1223 496023; E-mails: Suzanne.Turner@bbsrc.ac.uk, Denis.Alexander@BBSRC.AC.UK
Received 1 March 2005; Accepted 11 April 2005; Published online 19 May 2005.
Abstract
The nucleophosmin-anaplastic lymphoma kinase (NPM-ALK) is generated as a t(2;5) chromosomal breakpoint product, typically in CD30+ anaplastic large cell lymphomas. Activation of the NPM-ALK tyrosine kinase by NPM dimerisation causes autophosphorylation at multiple tyrosine residues and the consequent recruitment of a 'signalosome' that couples the fusion protein to pathways regulating mitogenesis and apoptosis. This review focuses on recent advances in our understanding of the transforming signals induced by this fusion protein in mouse models.
Keywords:
NPM-ALK, ALCL, oncogene, kinase
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
REVIEWS
The anaplastic lymphoma kinase in the pathogenesis of cancer
Nature Reviews Cancer Review (01 Jan 2008)
NEWS AND VIEWS
Validating Stat3 in cancer therapy
Nature Medicine News and Views (01 Jun 2005)
An enriched look at tyrosine phosphorylation
Nature Biotechnology News and Views (01 Jan 2005)
RESEARCH
Leukemia Original Article
Oncogene Original Article
